Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_1

20%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (20.0%)

Phase 21 (20.0%)

N/A3 (60.0%)

Trials by Status

completed480%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

unknownnot_applicable

The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study

NCT00535886

Clinical Trials (5)

Showing 5 of 5 trials

NCT03739463Not Applicable

Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity

Unknown

NCT01661764Phase 2

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Completed

NCT01043445Not Applicable

-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.

Completed

NCT01674946Phase 1

Effect of Bile Acids on the Secretion of Satiation Peptides in Humans

Completed

NCT00535886Not Applicable

The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study

Completed

All 5 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 5